Literature DB >> 17388915

Expression of differentiation associated protein Hes1 and Hes5 in cervical squamous carcinoma and its precursors.

J Liu1, F Ye, H Chen, W Lü, C Zhou, X Xie.   

Abstract

Hairy and Enhancer-of-split homologues 1 and 5 (Hes1 and Hes5) are the basic helix-loop-helix transcriptional factors that negatively regulate the cell differentiation during embryogenesis. It has been reported that they may be involved in carcinogenesis in some tumors. The roles of Hes1 and Hes5 in development and progression of cervical carcinoma are not well documented todate. In the study, the expression of Hes1 and Hes5 were detected by immunohistochemistry in 295 cases with various degrees of cervical epithelial lesions, including 78 normal cervical epithelia, 31 mild dysplasia (CIN I), 77 moderate-severe dysplasia (CIN II-III), and 109 squamous cervical carcinomas (SCCs), and their association with various clinical pathologic prognostic variables were analyzed in 73 early-stage SCC patients who underwent surgery. Hes1 and Hes5 expression were found to be significantly higher in SCC compared with CIN as well as higher in CIN than normal cervical epithelia, and positively correlated with various prognostic factors in early-stage cervical carcinoma. Our findings suggest that Hes1 and Hes5 may be involved in carcinogenesis of the cervix and progression of cervical carcinoma. Hes1 and Hes5 overexpression are probably variables to predict poor prognosis of the patients with early-stage cervical carcinoma.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17388915     DOI: 10.1111/j.1525-1438.2007.00930.x

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  9 in total

1.  HES1 as an independent prognostic marker in esophageal squamous cell carcinoma.

Authors:  Shaghayegh Taleb; Mohammad Reza Abbaszadegan; Meysam Moghbeli; Nasim Hayati Roudbari; Mohammad Mahdi Forghanifard
Journal:  J Gastrointest Cancer       Date:  2014-12

2.  Role for Notch signaling in salivary acinar cell growth and differentiation.

Authors:  Howard Dang; Alan L Lin; Binxian Zhang; Hong-Mei Zhang; Michael S Katz; Chih-Ko Yeh
Journal:  Dev Dyn       Date:  2009-03       Impact factor: 3.780

3.  Disease-specific gene repositioning in breast cancer.

Authors:  Karen J Meaburn; Prabhakar R Gudla; Sameena Khan; Stephen J Lockett; Tom Misteli
Journal:  J Cell Biol       Date:  2009-12-14       Impact factor: 10.539

4.  HES1 Protein Modulates Human Papillomavirus-Mediated Carcinoma of the Uterine Cervix.

Authors:  Richa Tripathi; Gayatri Rath; Vishwas Sharma; Showket Hussain; Shashi Sharma; Mausumi Bharadwaj; Ravi Mehrotra
Journal:  J Glob Oncol       Date:  2019-01

5.  Functional Gene Expression Differentiation of the Notch Signaling Pathway in Female Reproductive Tract Tissues-A Comprehensive Review With Analysis.

Authors:  Magdalena Orzechowska; Dorota Anusewicz; Andrzej K Bednarek
Journal:  Front Cell Dev Biol       Date:  2020-12-15

6.  Inhibition of gamma-secretase induces G2/M arrest and triggers apoptosis in breast cancer cells.

Authors:  S Rasul; R Balasubramanian; A Filipović; M J Slade; E Yagüe; R C Coombes
Journal:  Br J Cancer       Date:  2009-06-16       Impact factor: 7.640

7.  The expressions of bHLH gene HES1 and HES5 in advanced ovarian serous adenocarcinomas and their prognostic significance: a retrospective clinical study.

Authors:  Xinyu Wang; Yajuan Fu; Xiaoduan Chen; Jing Ye; Bingjian Lü; Feng Ye; Weiguo Lü; Xing Xie
Journal:  J Cancer Res Clin Oncol       Date:  2009-12-20       Impact factor: 4.553

8.  HES1, a target of Notch signaling, is elevated in canine osteosarcoma, but reduced in the most aggressive tumors.

Authors:  Deanna D Dailey; Kristin P Anfinsen; Liza E Pfaff; E J Ehrhart; J Brad Charles; Tina B Bønsdorff; Douglas H Thamm; Barbara E Powers; Thora J Jonasdottir; Dawn L Duval
Journal:  BMC Vet Res       Date:  2013-07-01       Impact factor: 2.741

Review 9.  Aberrant regulation of FBW7 in cancer.

Authors:  Lixia Wang; Xiantao Ye; Yueyong Liu; Wenyi Wei; Zhiwei Wang
Journal:  Oncotarget       Date:  2014-04-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.